Developing High-Yield and Safe Therapeutic EVs by Ablating Tissue Factor-Mediated Toxicity
Qingshan Luo, Xiang Li, Moxuan Yang, Xiaoyu Li, Shengya Xu, Tian Jiang, Junxian Xia, Jinfeng Ding, Xi Qin, Tong Zhao
This paper develops a genetically engineered EV platform that increases yield and eliminates toxicity, enabling safe high-dose systemic delivery.
bioRxiv · Dec 25, 2025 · PreprintBioengineering